Extension Study to Assess Batoclimab in Participants With Thyroid Eye Disease

NCT05517447 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
109
Enrollment
INDUSTRY
Sponsor class

Stopped The feeder studies (i.e., IMVT-1401-3201 and 3202) for study IMVT-1401-3203 failed to achieve their pre-defined primary efficacy outcomes. Accordingly, there was a change to the benefit-risk balance. No new safety findings were observed.

Conditions

Interventions

Sponsor

Immunovant Sciences GmbH